Loading company…
Tenaya Therapeutics is a California biopharmaceutical company developing treatments for heart disease.
Based in California, US, and founded in 2016, Tenaya Therapeutics uses regeneration, gene therapy and precision medicine platforms to develop therapies for heart disease. The company had 85 employees as of May 2021, and Faraz Ali has served as CEO since August 2021. In July 2021 it raised USD 180 million in an IPO on the Nasdaq, selling 12 million shares at USD 15 each.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in